Effects of tai chi on the protracted abstinence syndrome: A time trial analysis

American Journal of Chinese Medicine

Volumn 41, Issue 1, 2013, Pages 43-57

  Li, De Xiang ^a   Zhuang, Xin Ying ^b   Zhang, Yi Ping ^a   Guo, Hao ^b,c   Wang, Ze ^a   Zhang, Qing ^a   Feng, Yue Mei ^b   Yao, Yong Gang ^b  

^a Yunnan Provincial Key Laboratory of Criminal Science and Forensic Technology   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Heroin Addiction; HRSD; Physical Parameters; Protracted Abstinence Syndrome; Tai Chi

Indexed keywords

ADULT; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; FEMALE; HAMILTON SCALE; HEROIN DEPENDENCE; HUMAN; IMMUNE RESPONSE; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; PROTRACTED ABSTINENCE SYNDROME; RANDOMIZED CONTROLLED TRIAL; TAI CHI; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADULT; FEMALE; HEROIN; HUMANS; SUBSTANCE WITHDRAWAL SYNDROME; TAI JI; YOUNG ADULT;

EID: 84872935913     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X13500043     Document Type: Article

References (69)

1. Bize, R., J.A. Johnson and R.C. Plotnikoff. Physical activity level and health-related quality of life in the general adult population: A systematic review. Prev. Med. 45: 401-415, 2007
2. Bock, B.C., K.M. Morrow, B.M. Becker, D.M. Williams, G. Tremont, R.B. Gaskins, E. Jennings, J. Fava and B.H. Marcus. Yoga as a complementary treatment for smoking cessation: Rationale, study design and participant characteristics of the Quitting-in-Balance study. BMC Complement Altern. Med. 10: 14, 2010
3. Brown, D.D., W.G. Mucci, R.K. Hetzler and R.G. Knowlton. Cardiovascular and ventilatory responses during formalized Tai Chi Chuan exercise. Res. Q. Exerc. Sport 60: 246-250, 1989
4. Buysse, D.J., C.F. Reynolds, 3rd, T.H. Monk, S.R. Berman and D.J. Kupfer. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 28: 193-213, 1989
5. Carroll, M.E., W.J. Lynch, M.E. Roth, A.D. Morgan and K.P. Cosgrove. Sex and estrogen influence drug abuse. Trends Pharmacol. Sci. 25: 273-279, 2004
6. Eisenstein, T.K. and M.E. Hilburger. Opioid modulation of immune responses: Effects on phagocyte and lymphoid cell populations. J. Neuroimmunol. 83: 36-44, 1998
7. Emrich, H.M., L. Nusselt, C. Gramsch and S. John. Heroin addiction: Beta-endorphin immunoreactivity in plasma increases during withdrawal. Pharmacopsychiatria 16: 93-96, 1983
8. Gawin, F.H. and H.D. Kleber. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch. Gen. Psychiatry 43: 107-113, 1986
9. Gordon, D. Hematologic abnormalities and pain during acute opiate abstinence syndrome. Clin Toxicol. 12: 563-578, 1978
10. Guan, H. and D.M. Koceja. Effects of long-term Tai Chi practice on balance and H-reflex characteristics Am. J. Chin. Med. 39: 251-260, 2011
11. Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23: 56-62, 1960
12. Himmelsbach, C.K. Clinical studies of drug addiction - physical dependence, withdrawal and recovery. Arch. Intern. Med. 69: 766-772, 1942
13. Jahnke, R., L. Larkey, C. Rogers, J. Etnier and F. Lin. A comprehensive review of health benefits of qigong and Tai Chi. Am. J. Health Promot. 24: E1-e25, 2010
14. Kalechstein, A.D., T.F. Newton and A.H. Leavengood. Apathy syndrome in cocaine dependence Psychiatry Res. 109: 97-100, 2002
15. Leshner, A.I. Addiction is a brain disease, and it matters. Science 278: 45-47, 1997
16. Li, F., P. Harmer, K. Fitzgerald, E. Eckstrom, R. Stock, J. Galver, G. Maddalozzo and S.S. Batya. Tai Chi and postural stability in patients with Parkinson's disease. N. Engl. J. Med. 366: 511-519, 2012
17. Liu, C., G.Z. Xu and J.W. Zheng. Revision of rating scale for protracted withdrawal symptoms of heroin addicts. Chin. J. Drug Depend. 9: 132-135, 2000
18. Maciaszek, J. and W. Osinski. The effects of Tai Chi on body balance in elderly people - a review of studies from the early 21st century. Am. J. Chin. Med. 38: 219-229, 2010
19. McCarthy, L., M. Wetzel, J.K. Sliker, T.K. Eisenstein and T.J. Rogers. Opioids, opioid receptors and the immune response. Drug Alcohol Depend. 62: 111-123, 2001
20. Nestler, E.J. and G.K. Aghajanian. Molecular and cellular basis of addiction. Science 278: 58-63, 1997
21. Nunes, E.V., J.L. Rothenberg, M.A. Sullivan, K.M. Carpenter and H.D. Kleber. Behavioral therapy to augment oral naltrexone for opioid dependence: A ceiling on effectiveness? Am. J. Drug Alcohol Abuse 32: 503-517, 2006
22. Packer, N., L. Hoffman-Goetz and G. Ward. Does physical activity affect quality of life, disease symptoms and immune measures in patients with inflammatory bowel disease? A systematic review. J. Sports Med. Phys. Fitness 50: 1-18, 2010
23. Peles, E., T. Hetzroni, R. Bar-Hamburger, M. Adelson and S. Schreiber. Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: A double-blind randomized clinical trial. Addiction 102: 1947-1953, 2007
24. Penedo, F.J. and J.R. Dahn. Exercise and well-being: A review of mental and physical health benefits associated with physical activity. Curr. Opin. Psychiatry 18: 189-193, 2005
25. Reece, A.S. Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers. Immun. Ageing 4: 6, 2007
26. Rogers, C.E., L.K. Larkey and C. Keller. A review of clinical trials of Tai Chi and qigong in older adults. West J. Nurs. Res. 31: 245-279, 2009
27. Romero Zurita, A. Effects of Tai Chi on health-related quality of life in the elderly. Rev. Esp. Geriatr Gerontol. 45: 97-102, 2010
28. Schmidt, L.G., P. Dufeu, A. Heinz, S. Kuhn and H. Rommelspacher. Serotonergic dysfunction in addiction: Effects of alcohol, cigarette smoking and heroin on platelet 5-HT content. Psychiatry Res. 72: 177-185, 1997
29. Shippenberg, T.S., V.I. Chefer and A.C. Thompson. Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. Biol. Psychiatry 65: 169-174, 2009
30. Stein, M.D., D.S. Herman, S. Bishop, J.A. Lassor, M. Weinstock, J. Anthony and B.J. Anderson Sleep disturbances among methadone maintained patients. J. Subst. Abuse Treat. 26: 175-180, 2004
31. Ussher, M., A.K. Sampuran, R. Doshi, R. West and D.C. Drummond. Acute effect of a brief bout of exercise on alcohol urges. Addiction 99: 1542-1547, 2004
32. Vallejo, R., O. de Leon-Casasola and R. Benyamin. Opioid therapy and immunosuppression: A review. Am. J. Ther. 11: 354-365, 2004
33. Veilleux, J.C., P.J. Colvin, J. Anderson, C. York and A.J. Heinz. A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol. Rev. 30: 155-166, 2010
34. Wang, C., R. Bannuru, J. Ramel, B. Kupelnick, T. Scott and C.H. Schmid. Tai Chi on psychological well-being: Systematic review and meta-analysis. BMC Complement. Altern. Med. 10: 23, 2010
35. Wang, C., J.P. Collet and J. Lau. The effect of Tai Chi on health outcomes in patients with chronic conditions: A systematic review. Arch. Intern. Med. 164: 493-501, 2004
36. Ward, J., W. Hall and R.P. Mattick. Role of maintenance treatment in opioid dependence. Lancet 353: 221-226, 1999
37. Weinstock, J., D. Barry and N.M. Petry. Exercise-related activities are associated with positive outcome in contingency management treatment for substance use disorders. Addict. Behav. 33: 1072-1075, 2008
38. Yeh, S.H., H. Chuang, L.W. Lin, C.Y. Hsiao and H.L. Eng. Regular Tai Chi chuan exercise enhances functional mobility and CD4CD25 regulatory T cells. Br. J. Sports Med. 40: 239-243, 2006
39. Zhang, Y. and F.H. Fu. Effects of 14-week Tai Ji Quan exercise on metabolic control in women with type 2 diabetes. Am. J. Chin. Med. 36: 647-654, 2008
40. Zhdanova, I.V. and V.R. Piotrovskaya. Melatonin treatment attenuates symptoms of acute nicotine withdrawal in humans. Pharmacol. Biochem. Behav. 67: 131-135, 2000
41. Al-Suhaimi, E.A., N.A. Al-Riziza and R.A. Al-Essa. Physiological and therapeutical roles of ginger and turmeric on endocrine functions. Am. J. Chin. Med. 39: 215-231, 2011
42. Baum, L. and A. Ng. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. Alzheimer's Dis. 6: 367-377, 2004
43. Chomczynski, P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Bio. Techniques 15: 532-537, 1993
44. Cole, G.M., T. Morihara, G.P. Lim, F. Yang, A. Begum and S.A. Frautschy. NSAID and antioxidant prevention of Alzheimer's disease: Lessons from in vitro and animal models. Ann. N. Y. Acad Sci. l035: 68-84, 2004
45. Colton, C.A., M.P. Vitek, D.A. Wink, Q. Xu, V. Cantillana, M.L. Previti, W.E. Van Nostrand, J.B. Weinberg and H. Dawson. No synthase 2 deletion promotes multiple pathologies in a mouse model of Alzheimer's disease. Proc. Nat. Acad. Sci. USA 103: 12867-12872, 2006
46. Eng, L.F., R.S. Ghirnikar and Y.L. Lee. Glial fibrillary acidic protein: GFAP-thirty-one years (1969- 2000). J. Neurochem. Res. 25: 1439-1451, 2000
47. Gomez, G., G. Mansouraty, J. Gardea and M. Narayan. Acceleration of oxidative protein folding by curcumin through novel non-redox chemistry. Biochem. Biophys. Res. Commun. 364: 561-566, 2007
48. Jacobsen, J.S., C.C. Wu, J.M. Redwine, T.A. Comery, R. Arias, M. Bowlby, R. Martone, J.H. Morrison, M.N. Pangalos, P.H. Reinhart and F.E. Bloom. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 103: 5161-5166, 2006
49. Jiao, J., B. Xue, X. Wang and J. Xie. Research in mechanism of Aβ25-35-activated microglias. Chin J. Neuromed. 6: 571-574, 2007
50. Joe, B., M. Vijaykumar and B.R. Lokesh. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit. Rev. Food Sci. Nutr. 44: 97-111, 2004
51. Jorm, A.F. and D. Jolley. The incidence of dementia: A meta analysis. Neurology 51: 728-733, 1998
52. Kimura, N., M. Takahashi, T. Tashiro and K. Terao. Amyloid beta upregulates brain-derived neurotrophic factor production from astrocytes: Rescue from amyloid beta related neuritic degeneration. J. Neurosci. Res. 84: 782-789, 2006
53. Kozlov, A.S., M.C. Angulo, E. Audinat and S. Charpak. Target cell-specific modulation of neuronal activity by astrocytes. Neuroscience 103: 10058-10063, 2006
54. Kuner P., R. Schubenel and C. Hertel. Beta-amyloid binds to p57NTR and activates NF-kappaB in human neuroblastoma cells. J. Neurosci. Res. 54: 798-804, 1998
55. Mukhopadhyay, A., S. Banerjee, L.J. Stafford, C. Xia, M. Liu and B.B. Aggarwal. Curcumin induced suppression of cell proliferation correlates with downregulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21: 8852-8861, 2002
56. Nakamura, S., N. Murayama, T. Noshita, H. Annoura and T. Ohno. Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide. Brain Res. 912: 128-136, 2001
57. Ng, T.P., P.C. Chiam, T. Lee, H.C. Chua, L. Lim and E.H. Kua. Curry concumption and cognitive function in the elderly. Am. J. Epidemiol. 164: 898-906, 2006
58. Paxinos, G. and C. Watson. The Rat Brain in Stereotaxic Coordinates, Vol. 4. Academic Press, 1998, pp. 80-89
59. Pendurthi, U.R. and L.V. Rao. Suppression of transcription factor Eeg-1 by curcumin. Thromb. Res 179-189, 2000
60. Pertusa, M., S. García-Matas, E. Rodríguez-Farré, C. Sanfeliu and R. Cristòfol. Astrocytes aged in vitro show a decreased neuroprotective capacity. J. Neurochem. 101: 794-805, 2007
61. Reuss, B., R. Dono and K. Unsicker. Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglialdifferentiation and blood-brain barrier permeability: Evidence from mouse mutants J. Neurosci. 23: 6404-6412, 2003
62. Ribotta, M.G., V. Menet and A. Privat. Glial scar and axonal regeneration in the CNS: Lessons from GFAP and vimentin transgenic mice. J. Acta Neurochir. Suppl. 89: 87-92, 2004
63. Scheuner, D., C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T.D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe and S. Younkin. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2: 864-870, 1996
64. Singh, S. and B.B. Aggarwal. Activation of transcription factor NF-B is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 270: 24995-25000, 1995
65. Takeuchi, H., T. Kanzawa, Y. Kondo and S. Kondo. Inhibition of platelet-derived growth factor signaling induces autophagy in malignant glioma cells. Br. J. Cancer 90: 1069-1075, 2004
66. Tan, Z.S., A.S. Beiser, R.S. Vasan, R. Roubenoff, C.A. Dinarello, T.B. Harris, E.J. Benjamin, R. Au, D.P. Kiel, P.A. Wolf and A.S. Seshadri. Inflammatory markers and the risk of Alzheimer disease. Neurology 68: 1902-1908, 2007
67. Thiyagarajan, M. and S.S. Sharma. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 74: 969-985, 2004
68. Wyss-Coray, T., C. Lin, F. Yan, G.Q. Yu, M. Rohde, L. McConlogue, E. Masliah and L. Mucke TGF-betal promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7: 612-618, 2001
69. Yang, F., G.P. Lim, A.N. Begum, O.J. Ubeda, M.R. Simmons, S.S. Ambegaokar, P.P. Chen, R. Kayed, C.G. Glabe, S.A. Frautschy and G.M. Cole. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 280: 5892-590l, 2005